On its second-quarter fiscal 2027 earnings call, held on Oct. 21, 2026, NVE (NVEC +1.00%) announced that total revenue reached $16.9 million for the first six months of the fiscal year, up 36% over the prior period. This top-line growth highlights how commercial product demand and expanding distribution channels can offset temporary customer ordering delays in the medical device sector. For long-term investors, understanding the drivers behind product demand helps clarify the company's valuation trajectory. ...